The clinical outcomes are complex and often involve multiple systems. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory tests, and pathological activation.
The platform can help align domestic and foreign experts and teams to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune diseases that have previously been difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of herpes simplex disease. The platform serves the China International Medical Service System, a team of internationally authorized experts in the field of autoimmune and rheumatic immunity, to provide the following services to patients: Remote pre-diagnosis: by the team of experts to review the medical history, clarify diagnostic directions and provide medical advice: 1. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.